Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The physiology of the immune system involves morphologic and functional changes occurring along ageing, with a decrease in immune response and an increase in autoimmune phenomena, even in the absence of overt disese. Autoimmune cytopenias, namely autoimmune hemolytic anemia (AIHA), chronic idiopathic neutropenia (CIN) and aplastic anemia (AA), show different epidemiologic predilection, but are increasingly diagnosed in the elderly, where complications and comorbidities are more frequent. A systematic review of recent literature, shows that comorbidities as well as underlying deficiencies, medications, neoplasms, and, pathophysiologic chronic organ failures, frequently challenge the differential diagnosis in this setting and should always be evaluated and excluded. Complications, particularly infections and thrombosis for AIHA, and bleeding for AA, should be monitored and promptly treated. Treatment choice should be carefully weighed on the individual general condition and comorbidities, granted that intense primary care and support (including evidence-based transfusion policies) are provided. Finally, bone marrow histology is highly advisable in the elderly, both at diagnosis to detect underlying conditions, and along the follow-up to monitor possible bone marrow failure or neoplastic evolution.

Original languageEnglish
Pages (from-to)77-83
Number of pages7
JournalEuropean Journal of Internal Medicine
Volume58
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Autoimmune Hemolytic Anemia
Aplastic Anemia
Neutropenia
Comorbidity
Bone Marrow
Immune System
Primary Health Care
Histology
Thrombosis
Differential Diagnosis
Hemorrhage
Infection
Neoplasms
Therapeutics

Keywords

  • Aplastic anemia
  • Autoimmune hemolytic anemia
  • Autoimmune neutropenia
  • Elderly

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly. / Barcellini, Wilma; Fattizzo, Bruno; Cortelezzi, Agostino.

In: European Journal of Internal Medicine, Vol. 58, 01.12.2018, p. 77-83.

Research output: Contribution to journalArticle

@article{0f614b6201d544b3b1d1bf60ef7d6b3c,
title = "Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly",
abstract = "The physiology of the immune system involves morphologic and functional changes occurring along ageing, with a decrease in immune response and an increase in autoimmune phenomena, even in the absence of overt disese. Autoimmune cytopenias, namely autoimmune hemolytic anemia (AIHA), chronic idiopathic neutropenia (CIN) and aplastic anemia (AA), show different epidemiologic predilection, but are increasingly diagnosed in the elderly, where complications and comorbidities are more frequent. A systematic review of recent literature, shows that comorbidities as well as underlying deficiencies, medications, neoplasms, and, pathophysiologic chronic organ failures, frequently challenge the differential diagnosis in this setting and should always be evaluated and excluded. Complications, particularly infections and thrombosis for AIHA, and bleeding for AA, should be monitored and promptly treated. Treatment choice should be carefully weighed on the individual general condition and comorbidities, granted that intense primary care and support (including evidence-based transfusion policies) are provided. Finally, bone marrow histology is highly advisable in the elderly, both at diagnosis to detect underlying conditions, and along the follow-up to monitor possible bone marrow failure or neoplastic evolution.",
keywords = "Aplastic anemia, Autoimmune hemolytic anemia, Autoimmune neutropenia, Elderly",
author = "Wilma Barcellini and Bruno Fattizzo and Agostino Cortelezzi",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.ejim.2018.05.034",
language = "English",
volume = "58",
pages = "77--83",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly

AU - Barcellini, Wilma

AU - Fattizzo, Bruno

AU - Cortelezzi, Agostino

PY - 2018/12/1

Y1 - 2018/12/1

N2 - The physiology of the immune system involves morphologic and functional changes occurring along ageing, with a decrease in immune response and an increase in autoimmune phenomena, even in the absence of overt disese. Autoimmune cytopenias, namely autoimmune hemolytic anemia (AIHA), chronic idiopathic neutropenia (CIN) and aplastic anemia (AA), show different epidemiologic predilection, but are increasingly diagnosed in the elderly, where complications and comorbidities are more frequent. A systematic review of recent literature, shows that comorbidities as well as underlying deficiencies, medications, neoplasms, and, pathophysiologic chronic organ failures, frequently challenge the differential diagnosis in this setting and should always be evaluated and excluded. Complications, particularly infections and thrombosis for AIHA, and bleeding for AA, should be monitored and promptly treated. Treatment choice should be carefully weighed on the individual general condition and comorbidities, granted that intense primary care and support (including evidence-based transfusion policies) are provided. Finally, bone marrow histology is highly advisable in the elderly, both at diagnosis to detect underlying conditions, and along the follow-up to monitor possible bone marrow failure or neoplastic evolution.

AB - The physiology of the immune system involves morphologic and functional changes occurring along ageing, with a decrease in immune response and an increase in autoimmune phenomena, even in the absence of overt disese. Autoimmune cytopenias, namely autoimmune hemolytic anemia (AIHA), chronic idiopathic neutropenia (CIN) and aplastic anemia (AA), show different epidemiologic predilection, but are increasingly diagnosed in the elderly, where complications and comorbidities are more frequent. A systematic review of recent literature, shows that comorbidities as well as underlying deficiencies, medications, neoplasms, and, pathophysiologic chronic organ failures, frequently challenge the differential diagnosis in this setting and should always be evaluated and excluded. Complications, particularly infections and thrombosis for AIHA, and bleeding for AA, should be monitored and promptly treated. Treatment choice should be carefully weighed on the individual general condition and comorbidities, granted that intense primary care and support (including evidence-based transfusion policies) are provided. Finally, bone marrow histology is highly advisable in the elderly, both at diagnosis to detect underlying conditions, and along the follow-up to monitor possible bone marrow failure or neoplastic evolution.

KW - Aplastic anemia

KW - Autoimmune hemolytic anemia

KW - Autoimmune neutropenia

KW - Elderly

UR - http://www.scopus.com/inward/record.url?scp=85048347780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048347780&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2018.05.034

DO - 10.1016/j.ejim.2018.05.034

M3 - Article

C2 - 30527923

AN - SCOPUS:85048347780

VL - 58

SP - 77

EP - 83

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

ER -